Characterization of patient-reported outcomes in moderate to severe psoriasis

Dermatology

Volumn 223, Issue 1, 2011, Pages 80-86

  Krenzer, Stefanie ^a   Radtke, Marc ^b   Schmitt Rau, Karlheinz ^b,c   Augustin, Matthias ^b  

^a Merck Serono GmbH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Sr healthcare Management ^*  (Germany)

Author keywords

Health related quality of life; Patient benefit index; Patient reported outcomes; Psoriasis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY SURFACE; CLINICAL ASSESSMENT TOOL; CORRELATIONAL STUDY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; QUALITY OF LIFE; SELF REPORT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY SURFACE AREA; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSORIASIS; QUALITY OF LIFE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053956677     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000330560     Document Type: Article

References (17)

1. Schaefer I, Rustenbach S, Zimmer L, Augustin, M: Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169-172.
2. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M: Comorbidity and age-related prevalence of psoriasis-analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-151.
3. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T: The impact of psoriasis on quality of life-results of a 1998 National Psoriasis Foundation Patient-Membership Survey. Arch Dermatol 2001; 137: 280-284. (Pubitemid 32240779)
4. Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti S, Lotti T, Schäfer G, EUROPSO Patient Survey group: European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-736. (Pubitemid 44352553)
5. EUROPSO: The EUROPSO psoriasis patient study: treatment history and satisfaction reported by 17,990 members of European psoriasis patient associations. Helsinki, EUROPSO, 2002. www.europso.eu/media/archive2/europso- survey-en.pdf.
6. Bullinger M, Kirchberger I, Ware J: Der deutsche SF-36 Health Survey. Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instruments zur Erfassung der gesundheitsbezogenen Le bensqualität. Z Gesundh Wiss 1995; 3: 21-36.
7. Finlay A, Khan G: Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
8. Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, Reusch M, Mielke V, Rustenbach SJ: The Patient Benefit Index (PBI)-a novel approach in patient defined outcomes measurement for skin diseases. Arch Dermatol Res 2009; 301: 561-571.
9. Blome C, Augustin A, Behechtnejad J, Rustenbach F: Dimensions of patient needs in dermatology: subscales of the patient benefit index. Arch Dermatol Res 2011; 303: 11-17.
10. Blome C, Simianer S, Purwins S, Laass A, Rustenbach SF, Schaefer I, Radtke M, Augustin A: Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology 2010; 221: 154-159.
11. de Korte J, Sprangers MAG, Mombers FMC, Bos JD: Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004; 9: 140-147. (Pubitemid 38457272)
12. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ: Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-708. (Pubitemid 39516879)
13. Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U: Lebensqualität bei Hauterkrankungen: Vergleich verschiedener Lebensqualitäts-Fragebögen bei Psoriasis und atopischer Dermatitis (Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis). Hautarzt 1999; 50: 715-722. (Pubitemid 29502766)
14. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K: Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372. (Pubitemid 351630108)
15. Augustin M, Lange S, Wenninger K, Seidenglanz K, Amon U, Zschocke I: Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 2004; 14: 107-113. (Pubitemid 38510027)
16. Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY: Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001; 144: 967-972.
17. Schäfer I, Hacker J, Rustenbach SJ, Radtke M, Franzke N, Augustin M: Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol 2010;20:62-67.